Accelerated development of vaccine benefit-risk collaboration in Europe
Displaying results 1 - 10 of 78
Standardization and development of assays for assessment of influenza vaccines correlates of protection
Vaccine potency drops in the elderly and little is known about why this happens. Now European scientists are on a mission to understand waning immunity and to develop strategies...
COVID-19 vaccines do not raise the risk of developing four rare neurological disorders, but an increased risk was seen in unvaccinated infected people with the disease.